Equate Allergy Relief

Manufacturer: Wal-Mart Stores, Inc. | Cipla Ltd. | Cipla limited
Effective date: 2015-08-03
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:29:49

Label at a glance#

ProductEquate Allergy Relief

Active ingredientcetirizine hydrochloride

Label structure14 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itchy throat or nose

Dosage and administration

adults and children 6 years and over one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. adults 65 years and over ask a doctor children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-888-287-1915

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Cetirizine HCl 10 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

runny nose
sneezing
itchy, watery eyes
itchy throat or nose

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

When using this product

OTC - WHEN USING SECTION

drowsiness may occur
avoid alcoholic drinks
alcohol, sedatives, and tranquilizers may increase drowsiness
be careful when driving a motor vehicle or operating machinery.

Stop use and ask a doctor if

OTC - STOP USE SECTION

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

OTC - PREGNANCY OR BREAST FEEDING SECTION

if breast-feeding: not recommended
if pregnant: ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 years and over	one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
adults 65 years and over	ask a doctor
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

Other information

OTHER SAFETY INFORMATION

do not use if printed foil under cap broken or missing
store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Colloidal silicon dioxide, Hypromellose, lactose monohydrate, low-substituted hydroxyporpyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol and titanium dioxide.

Questions or Comments?

OTC - QUESTIONS SECTION

1-888-287-1915

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49035-312-56

equate^™

Allergy Relief

Cetirizine Hydrochloride Tablets USP, 10 mg
Antihistamine

Indoor and Outdoor Allergies

24 Hour Relief of:

Sneezing
Runny nose
Itchy, watery eyes
Itchy throat or nose

24
HOUR
SYMPTOM

RELIEF

Original Prescription Strength

10 mg

14 TABLETS

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49035-312-57

equate^™

Allergy
Relief

Cetirizine Hydrochloride
Tablets USP, 10 mg/Antihistamine

Indoor and Outdoor Allergies

24 Hour Relief of:

Sneezing
Runny nose
Itchy, watery eyes
Itchy throat or nose

24
HOUR
SYMPTOM

RELIEF

Original
Prescription Strength

10 mg

45 TABLETS

Principal Display Panel - Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

equate^™

NDC 49035-312-57

Allergy Relief

Cetirizine Hydrochloride
Tablets USP, 10 mg

Antihistamine

Original
Prescription
Strength

45 Tablets

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49035-312-05

equate^™

Allergy
Relief

Cetirizine Hydrochloride
Tablets USP, 10 mg/Antihistamine

Indoor and Outdoor Allergies

24 Hour Relief of:

Sneezing
Runny nose
Itchy, watery eyes
Itchy throat or nose

24
HOUR
SYMPTOM

RELIEF

Original
Prescription Strength

10 mg

90 TABLETS

Principal Display Panel - Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

equate^™

NDC 49035-312-05

Allergy Relief

Cetirizine Hydrochloride
Tablets USP, 10 mg

Antihistamine

Original
Prescription
Strength

90 Tablets

Principal Display Panel - Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49035-312-58

equate^™

Allergy Relief

Cetirizine Hydrochloride
Tablets USP,
10 mg/Antihistamine

Indoor and
Outdoor Allergies

24 Hour Relief of:

Sneezing
Runny nose
Itchy, watery eyes
Itchy throat or nose

24
HOUR
SYMPTOM

RELIEF

Original Prescription Strength

10 mg

180 TABLETS

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49035-312-05	2025-12-29	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-56	2025-12-29	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-57	2025-12-29	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-58	2025-12-29	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-05	2020-01-31	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-56	2020-01-31	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-57	2020-01-31	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts
49035-312-58	2020-01-31	C162847	48780-1	9d75b9d0-d711-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49035-312	EQUATE ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE) TABLET, FILM COATED [WAL-MART STORES, INC.]	2	Legacy NDC	20151204_d641a0ac-9d74-440a-94fd-699ab0fe513d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
cetirizine hydrochloride	ACTIVE INGREDIENT	64O047KTOA	1
cetirizine	ACTIVE MOIETY	YO7261ME24	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	1
colloidal silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
hydroxypropyl cellulose, low substituted	INACTIVE INGREDIENT	2165RE0K14	1
hypromellose 2910 (15 MPA.S)	INACTIVE INGREDIENT	36SFW2JZ0W	1
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	1
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Equate Allergy Relief
cetirizine hydrochloride
cetirizine
colloidal silicon dioxide
hypromellose 2910 (15 MPA.S)
lactose monohydrate
hydroxypropyl cellulose, low substituted
magnesium stearate
cellulose, microcrystalline
polyethylene glycols
titanium dioxide

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49035-312	49035-312-56, 49035-312-57, 49035-312-05, 49035-312-58

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
cetirizine hydrochloride	64O047KTOA	ACTIB
colloidal silicon dioxide	ETJ7Z6XBU4	IACT
hypromellose 2910 (15 MPA.S)	36SFW2JZ0W	IACT
lactose monohydrate	EWQ57Q8I5X	IACT
hydroxypropyl cellulose, low substituted	2165RE0K14	IACT
magnesium stearate	70097M6I30	IACT
cellulose, microcrystalline	OP1R32D61U	IACT
polyethylene glycols	3WJQ0SDW1A	IACT
titanium dioxide	15FIX9V2JP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 212 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	47.5 mg		Exact identifier — unii candidate 38 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	FILM, EXTENDED RELEASE / TRANSDERMAL	49 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		53 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
hypromellose 2910 (15 MPA.S)	HYPROMELLOSE 2910 (15 MPA.S)	36SFW2JZ0W	SOLUTION / OPHTHALMIC	0.5 %w/v		Exact identifier — unii candidate 14 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR		214 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / NASAL		20 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, DELAYED RELEASE / ORAL		2210 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
hydroxypropyl cellulose, low substituted	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE	2165RE0K14	CAPSULE / ORAL		150 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET / BUCCAL		43 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	PASTE, DENTIFRICE / DENTAL	0.4 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, EXTENDED RELEASE / ORAL		2575 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		150 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 38 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CREAM / TOPICAL		80 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, FILM COATED / ORAL		36 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / VAGINAL	8 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
hypromellose 2910 (15 MPA.S)	HYPROMELLOSE 2910 (15 MPA.S)	36SFW2JZ0W	CAPSULE, DELAYED RELEASE / ORAL		129 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, EXTENDED RELEASE / ORAL		90 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / ORAL		50 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE, LIQUID FILLED / ORAL		12 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET, COATED / ORAL		1301 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	TABLET / SUBLINGUAL		505 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, FOR SUSPENSION / ORAL		131 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / ORAL		420 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PASTE / DENTAL	34 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, CHEWABLE / ORAL		1725 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / ORAL		300 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE / ORAL		2169 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
hypromellose 2910 (15 MPA.S)	HYPROMELLOSE 2910 (15 MPA.S)	36SFW2JZ0W	FILM, SOLUBLE / ORAL		47 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	GRANULE, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 38 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	GRANULE, FOR SUSPENSION / ORAL		14 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	GUM, CHEWING / BUCCAL		182 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	DROPS / ORAL	NA		Exact identifier — unii candidate 40 equally ranked IID candidates
hypromellose 2910 (15 MPA.S)	HYPROMELLOSE 2910 (15 MPA.S)	36SFW2JZ0W	SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	INHALANT / ORAL	NA		Exact identifier — unii candidate 38 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE / ORAL		29520 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FOR SUSPENSION / ORAL		20100 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
colloidal silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
lactose monohydrate	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / RESPIRATORY (INHALATION)		25 mg	Exact identifier — unii candidate 38 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		42 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
hydroxypropyl cellulose, low substituted	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE	2165RE0K14	TABLET, DELAYED RELEASE / ORAL		103 mg	Exact identifier — unii candidate 4 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	CETIRIZINE HYDROCHLORIDE	5MG	TABLET / ORAL			2013-07-25
A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	CETIRIZINE HYDROCHLORIDE	10MG	TABLET / ORAL			2013-07-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077318-001	CETIRIZINE HYDROCHLORIDE ALLERGY	5MG	TABLET / ORAL	2013-07-25	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077318-002	CETIRIZINE HYDROCHLORIDE ALLERGY	10MG	TABLET / ORAL	2013-07-25	`4b0b4de00fa7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
7c4dcbf3-5a6f-49c1-9256-33036b9377a5			d641a0ac-9d74-440a-94fd-699ab0fe513d	2025-12-24	Warnings	Exact identifier spl set id: d641a0ac-9d74-440a-94fd-699ab0fe513d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.